.png)
.png)
When staff at NHS South Yorkshire were told last September that their chief executive, Gavin Boyle, had decided to retire after more than three decades in the health service, the announcement read as a dignified send-off for a long-serving leader. What went unmentioned at the time was the size of the package attached to his departure in mid-October, and the fact that it had been processed not as a retirement but as a compulsory redundancy.
The figure, reported by the Health Service Journal in January, comes to around £300,000. It combines the maximum contractual NHS redundancy entitlement of £160,000 with several months' pay in lieu of notice under Very Senior Manager terms. Boyle had led the ICB since its creation in 2022 and had spent 18 years at chief executive level across a series of trusts before that. None of this is in dispute. What has drawn sustained criticism from unions, and questions in Parliament about how special severance payments across the NHS are approved and disclosed, is the gap between what staff were told and what the paperwork shows.
Sarah Dodsworth, regional director of the Royal College of Nursing for Yorkshire and the Humber, described the arrangement as egregiously unfair and highlighted the concerns of rank-and-file employees who had been left in the dark for months about their own jobs, their own redundancy terms, or whether the ICB was even able to fund them That contrast sits at the heart of the row. South Yorkshire ICB has been told to cut its operating costs from £61.7 million to £30.2 million and to reduce its workforce from around 800 whole-time equivalent posts to 425, part of a national programme to consolidate integrated care boards that ministers estimate will cost in the region of £1 billion to deliver. Against that backdrop, a six-figure exit payment for a departing executive, quietly categorised in a way that unlocked the fullest available entitlement, was always going to draw attention.
NHS England's position, echoed by government ministers including Baroness Merron in the Lords, is that the payment was contractually compliant. Boyle, officials say, had already been placed within a cohort of ICB leaders earmarked for compulsory redundancy as part of the national restructuring, a designation made before any internal communication about retirement went out. If that sequencing holds up, the payment may be defensible on paper even as it remains difficult to justify politically. The problem for NHS England is that both things can be true at once. At a time when every pound spent on senior staff exits is a pound not spent on patient care or on employees who are losing their jobs involuntarily, a severance package that fully complies with the Agenda for Change and VSM frameworks may still appear indefensible to a labour force being asked to agree to redundancy terms far less generous.
This is the pattern that has repeatedly attached itself to NHS restructuring under Sir Jim Mackey's leadership of NHS England: reforms that are procedurally sound but poorly communicated, leaving room for exactly the kind of scrutiny now facing this case. Special severance payments already require Treasury sign-off under Managing Public Money guidance, precisely because they carry reputational risk beyond their immediate cost. The RCN and other unions are now pressing for full oversight records to be published and for the approval process behind this exit to be reviewed, arguments that will gain force if it emerges that other departing ICB executives have received comparable packages without equivalent disclosure to staff.
The broader lesson for NHS leadership extends well beyond South Yorkshire. As the service consolidates 42 integrated care boards into a smaller number of larger bodies, every executive exit will now invite comparison with the terms offered to the staff being made redundant beneath them. Transparency about how those decisions are made, and communicated, has become as important to public trust as the decisions themselves.